Jennifer Tousignant insider trades
Open-market stock purchases and sales by Jennifer Tousignant, Chief Legal Officer at Viridian Therapeutics, Inc.\DE, from SEC Form 4 filings since Feb 12, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 19, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sold | $103K |
| Aug 19, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | $144K |
| Aug 19, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sold | $245K |
| Aug 19, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sold (not open market) | $50.5K |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sold (not open market) | $50.6K |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |
| Dec 31, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Sold | $70.8K |
Companies traded
- VRDN Viridian Therapeutics, Inc.\DE: 3 sales, last Aug 19, 2026
Get free alerts when Jennifer Tousignant files a new trade →